Basic Information
RNALocate ID: | RLID-D:11004104 |
RNA Symbol: | hsa-miR-298 |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-298 |
RNA ID: | miRBase:MIMAT0004901 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004097 | Exosome | Serum | 18589210 |
RLID:11004098 | Exosome | K562 cells | 24460325 |
RLID-D:11001584 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-298 | Lymphoma | MNDR-E-MI-34430 |
MNDR | hsa-miR-298 | Estrogen-receptor positive breast cancer | MNDR-E-MI-34431 |
MNDR | hsa-miR-298 | Estrogen-receptor negative breast cancer | MNDR-E-MI-34432 |
MNDR | hsa-miR-298 | Progesterone-receptor positive breast cancer | MNDR-E-MI-34433 |
MNDR | hsa-miR-298 | Progesterone-receptor negative breast cancer | MNDR-E-MI-34434 |
MNDR | hsa-miR-298 | Her2-receptor positive breast cancer | MNDR-E-MI-34435 |
MNDR | hsa-miR-298 | Breast cancer luminal | MNDR-E-MI-34436 |
MNDR | hsa-miR-298 | Gastric cancer | MNDR-E-MI-34437 |
MNDR | hsa-miR-298 | Alzheimer disease | MNDR-E-MI-34438 |
MNDR | hsa-miR-298 | Intracranial aneurysm | MNDR-E-MI-34439 |
MNDR | hsa-miR-298 | Lung cancer | MNDR-E-MI-34440 |
MNDR | hsa-miR-298 | Parkinson disease | MNDR-E-MI-34441 |
MNDR | hsa-miR-298 | Basal-like breast cancer | MNDR-E-MI-34442 |
MNDR | hsa-mir-298 | Breast cancer | MNDR-E-MI-34443 |
MNDR | hsa-miR-298 | Thyroid cancer | MNDR-E-MI-34444 |
MNDR | hsa-miR-298 | Pancreatic cancer | MNDR-E-MI-34445 |
MNDR | hsa-miR-298 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-34446 |
MNDR | hsa-miR-298 | Familial ovarian cancer | MNDR-E-MI-34447 |
MNDR | hsa-miR-298 | Glioblastoma | MNDR-E-MI-34448 |
MNDR | hsa-miR-298 | Meningioma | MNDR-E-MI-34449 |
MNDR | hsa-miR-298 | Lung adenocarcinoma | MNDR-E-MI-34450 |
MNDR | hsa-miR-298 | Biliary tract cancer | MNDR-E-MI-34451 |
MNDR | hsa-miR-298 | Cholangiocarcinoma | MNDR-E-MI-34452 |
MNDR | hsa-miR-298 | Hepatocellular carcinoma | MNDR-E-MI-34453 |
MNDR | hsa-mir-298 | Hepatocellular carcinoma | MNDR-E-MI-34454 |
MNDR | hsa-miR-298 | Familiar ovarian carcinoma | MNDR-E-MI-34455 |
MNDR | hsa-miR-298 | Hodgkin lymphoma | MNDR-E-MI-34456 |
MNDR | hsa-mir-298 | Thrombocytopenic purpurea autoimmune | MNDR-E-MI-34457 |
MNDR | hsa-mir-298 | Systemic lupus erythematosus | MNDR-E-MI-34458 |
MNDR | hsa-miR-298 | Colorectal cancer | MNDR-E-MI-34459 |
MNDR | hsa-miR-298 | Nasopharynx carcinoma | MNDR-E-MI-34460 |
MNDR | hsa-mir-298 | Cerebral hemorrhage | MNDR-E-MI-34461 |
MNDR | hsa-miR-298 | Nasopharyngeal cancer | MNDR-E-MI-34462 |
MNDR | hsa-mir-298 | Stroke | MNDR-E-MI-34463 |
MNDR | hsa-miR-298 | Breast cancer her3+ negative | MNDR-E-MI-34464 |
MNDR | hsa-mir-298 | Systemic lupus erythematosus susceptibility | MNDR-E-MI-34465 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BACE1 | Homo sapiens | RR00209216 |
TOP